Asiaticoside for overweight and obesity
Part of Hormones & metabolism clinical trials.
This study tests whether a natural compound called asiaticoside can help people who are overweight or have obesity. If you are an adult with a body mass index (BMI) between 24 and 45, you may be able to join and see if the treatment helps with weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your body mass index (BMI) must be between 24 and 45.
- You cannot have certain serious health conditions like active tuberculosis, cancer, or HIV.
- You cannot have severe liver or kidney problems.
- You cannot have had a heart attack, stroke, or major heart condition in the last 6 months.
- You must not smoke or have used tobacco in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.
This study tests a new medicine called Zenagamtide to help people with excess body weight lose weight. It is designed for adults in Asia who do not have diabetes.
This trial tests an investigational once-daily pill (ASC30) to see if it can help adults with overweight or obesity lose weight. You may be able to join if you have a high body mass index (BMI) and have tried to lose weight before.
This study tests a new medication called DA-302168S to help people lose weight. You may qualify if you're overweight or obese and meet certain health requirements.
This trial tests a new medicine called AZD1043 in healthy adults who are overweight or have obesity. It aims to see if the medicine is safe and how the body handles it.
This study tests an oral medication, ASC30, to see if it helps people with type 2 diabetes who are overweight or obese lose weight and improve blood sugar control. It is a once-daily pill that may offer a new treatment option.
Hear when a new Overweight , Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.